|
1
|
Catalano V, Labianca R, Beretta GD, Gatta
G, de Braud F and Van Cutsem E: Gastric cancer. Crit Rev Oncol
Hematol. 71:127–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chan AO, Luk JM, Hui WM and Lam SK:
Molecular biology of gastric carcinoma: From laboratory to bedside.
J Gastroenterol Hepatol. 14:1150–1160. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fenoglio-Preiser CM, Wang J, Stemmermann
GN and Noffsinger A: TP53 and gastric carcinoma: A review. Hum
Mutat. 21:258–270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lin ZQ, Lv P, Lu XX, Yu JL, Han J, Ying
LS, Zhu X, Zhu WY, Fang XH, Wang S and Wu YC: Circulating
methylated XAF1 DNA indicates poor prognosis for gastric cancer.
PLoS One. 8:e671952013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li YL, Liu L, Xiao Y, Zeng T and Zeng C:
14-3-3σ is an independent prognostic biomarker for gastric cancer
and is associated with apoptosis and proliferation in gastric
cancer. Oncol Lett. 9:290–294. 2015.PubMed/NCBI
|
|
6
|
Valladares-Ayerbes M, Reboredo M,
MedinaVillaamil V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Haz M,
Santamaria I, Blanco M, Fernández-Tajes J, Quindós M, et al:
Circulating miR-200c as a diagnostic and prognostic biomarker for
gastric cancer. J Transl Med. 10:1862012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi K and Yamanaka S: Induction of
pluripotent stem cells from mouse embryonic and adult fibroblast
cultures by defined factors. Cell. 126:663–676. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yu J, Vodyanik MA, SmugaOtto K,
AntosiewiczBourget J, Frane JL, Tian S, Nie J, Jonsdottir GA,
Ruotti V, Stewart R, et al: Induced pluripotent stem cell lines
derived from human somatic cells. Science. 318:1917–1920. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li N, Deng W, Ma J, Wei B, Guo K, Shen W,
Zhang Y and Luo S: Prognostic evaluation of Nanog, Oct4, Sox2,
PCNA, Ki67 and E-cadherin expression in gastric cancer. Med Oncol.
32:4332015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al-Marzoqee FY, Kholder G, AlAwadhi H,
John R, Beg A, Vincze A, Branicki F and Karam SM: Upregulation and
inhibition of the nuclear translocation of Oct4 during multistep
gastric carcinogenesis. Int J Oncol. 41:1733–1743. 2012.PubMed/NCBI
|
|
11
|
Tian T, Zhang Y, Wang S, Zhou J and Xu S:
Sox2 enhances the tumorigenicity and chemoresistance of cancer
stem-like cells derived from gastric cancer. J Biomed Res.
26:336–345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Otsubo T, Akiyama Y, Yanagihara K and
Yuasa Y: SOX2 is frequently downregulated in gasyric cancers and
and inhibits cell growth through cell-cycle arrest and apoptosis.
Br J Cancer. 98:824–831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evans PM and Liu C: Roles of Krüpel-like
factor 4 in normal homeostasis, cancer and stem cells. Acta Biochim
Biophys Sin (Shanghai). 40:554–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei D, Gong W, Kanai M, Schlunk C, Wang L,
Yao JC, Wu TT, Huang S and Xie K: Drastic down-regulation of
Krüppel-like factor 4 Expression is critical in human gastric
cancer development and progression. Cancer Res. 65:2746–2754. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sobin LH, Gospodarowicz MK and Wittekind
C: International Union Against Cancer (UICC) TNM Classification of
Malignant Tumors. 7th. Wiley-Blackwell; New York: 2010
|
|
16
|
McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP
and Wasif N: Validation of the updated 7th edition AJCC TNM staging
criteria for gastric adenocarcinoma. J Gastrointest Surg. 16:53–61.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fukuoka J, Fujii T, Shih JH, Dracheva T,
Meerzaman D, Player A, Hong K, Settnek S, Gupta A, Buetow K, et al:
Chromatin remodeling factors and BRM/BRG1 expression as prognostic
indicators in non-small cell lung cancer. Clin Cancer Res.
10:4314–4324. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sekine S, Shimada Y, Nagata T, Moriyama M,
Omura T, Watanabe T, Hori R, Yoshioka I, Okumura T, Sawada S, et
al: Prognostic significance of aquaporins in human biliary tract
carcinoma. Oncol Rep. 27:1741–1747. 2012.PubMed/NCBI
|
|
19
|
Garrett-Sinha LA, Eberspaecher H, Seldin
MF and de Crombrugghe B: A gene for a novel zinc-finger protein
expressed in differentiated epithelial cells and transiently in
certain mesenchymal cells. J Biol Chem. 271:31384–31390. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shields JM, Christy RJ and Yang VW:
Identification and characterization of a gene encoding a
gut-enriched Krüppel-like factor expressed during growth arrest. J
Biol Chem. 271:20009–20017. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Z Jun Z Neng, Leiyuan S, Lang Z, Miao H,
Zhen H and Ziwei W: Krüppel-like factor 4 negatively regulates
β-catenin expression and inhibits the proliferation, invasion and
metastasis of gastric cancer. Int J Oncol. 40:2038–2048.
2012.PubMed/NCBI
|
|
22
|
Liu Z, Yang H, Luo W, Jiang Q, Mai C, Chen
Y, Zhen Y, Yu X, Long X and Fang W: Loss of cytoplasmic KLF4
expression is correlated with the progression and poor prognosis of
nasopharyngeal carcinoma. Histopathology. 63:362–370. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen CJ, Hsu LS, Lin SH, Chen MK, Wang HK,
Hsu JD, Lee H and Yeh KT: Loss of nuclear expression of
Krüppel-like factor 4 is associated with poor prognosis in patients
with oral cancer. Hum Pathol. 43:1119–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li J, Zheng H, Yu F, Yu T, Liu C, Huang S,
Wang TC and Ai W: Deficiency of the Krüppel-like factor KLF4
correlates with increased cell proliferation and enhanced skin
tumorigenesis. Carcinogenesis. 33:1239–1246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu Y, Zhang C, Fan J, Xiao L, Yin B, Zhou
K and Xia S: Comprehensive analysis of clinical significance of
stem-cell related factors in renal cell cancer. World J Surg Oncol.
9:1212011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hu W, Hofstetter WL, Li H, Zou Y, He Y,
Pataer A, Wang L, Xie K, Swisher SG and Fang B: Putative
tumor-suppressive function of Krüppel-like factor 4 in primary lung
carcinoma. Clin Cancer Res. 15:5688–5695. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang WT and Zheng PS: Krüppel-like factor
4 functions as a tumor suppressor in cervical carcinoma. Cancer.
118:3691–3702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nagata T, Shimada Y, Sekine S, Hori R,
Matsui K, Okumura T, Sawada S, Fukuoka J and Tsukada K: Prognostic
significance of NANOG and KLF4 for breast cancer. Breast Cancer.
21:96–101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tiwari N, MeyerSchaller N, Arnold P,
Antoniadis H, Pachkov M, van Nimwegen E and Christofiri G: Klf4 is
a transcriptional regulator of genes critical for EMT, including
Jnk1 (Mapk8). PLoS One. 8:e573292013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou Y, Hofstetter WL, He Y, Hu W, Pataer
A, Wang L, Wang J, Zhou Y, Yu L, Fang B and Swisher SG: KLF4
inhibition of lung cancer cell invasion by suppression of SPARC
expression. Cancer Biol Ther. 9:507–513. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Leng Z, Tao K, Xia Q, Tan J, Yue Z, Chen
J, Xi H, Li J and Zheng H: Krüppel-like factor 4 acts as an
oncogene in colon cancer stem cell-enriched spheroid cells. PLoS
One. 8:e560822013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang Y, Goldstein BG, Chao HH and Katz JP:
KLF4 and KLF5 regulate proliferation, apoptosis and invasion in
esophageal cancer cells. Cancer Biol Ther. 4:1216–1221. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ohnishi S, Ohnami S, Laub F, Aoki K,
Suzuki K, Kanai Y, Haga K, Asaka M, Ramirez F and Yoshida T:
Downregulation and growth inhibitory effect of epithelial-type
Krüppel-like transcription factor KLF4, but not KLF5, in bladder
cancer. Biochem Biophys Res Commun. 308:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tang W, Zhu Y, Gao J, Fu J, Liu C, Liu Y,
Song C, Zhu S, Leng Y, Wang G, et al: MicroRNA-29 promotes
colorectal cancer metastasis by regulating matrix metalloproteinase
2 and E-cadherin via KLF4. Br J Cancer. 110:450–458. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gastric Cancer treatment guidelines 2014,
version 4. Kodera Y and Sano T: Japanese Gastric Cancer
Association; 2014
|
|
36
|
Chen ZY, Shie J and Tsen C: Up-regulation
of gut-enriched krüppel-like factor by interferon-gamma in human
colon carcinoma cells. FEBS Lett. 477:67–72. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yasunaga J, Taniguchi Y, Nosaka K, Yoshida
M, Satou Y, Sakai T, Mitsuya H and Matsuoka M: Identification of
aberrantly methylated genes in association with adult T-cell
leukemia. Cancer Res. 64:6002–6009. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shie JL, Chen ZY, Fu M, Pestell RG and
Tseng CC: Gut-enriched Krüppel-like factor represses cyclin D1
promoter activity through Sp1 motif. Nucleic Acids Res.
28:2969–2976. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Tiwari N, MeyerSchaller N, Arnold P,
Antoniadis H, Pachkov M, van Nimwegen E and Chritofori G: Klf4 is a
transcriptional regulator of genes critical for EMT, including Jnk1
(Mapk8). PLoS One. 8:e573292013. View Article : Google Scholar : PubMed/NCBI
|
